Betamethasone dipropionate; clotrimazole - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for betamethasone dipropionate; clotrimazole and what is the scope of patent protection?
Betamethasone dipropionate; clotrimazole
is the generic ingredient in two branded drugs marketed by Actavis Mid Atlantic, Fougera Pharms, Glenmark Speclt, Taro, Organon, and Merck Sharp Dohme, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.Seventeen suppliers are listed for this compound.
Summary for betamethasone dipropionate; clotrimazole
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 6 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 17 |
Clinical Trials: | 1 |
DailyMed Link: | betamethasone dipropionate; clotrimazole at DailyMed |
Recent Clinical Trials for betamethasone dipropionate; clotrimazole
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
See all betamethasone dipropionate; clotrimazole clinical trials